OSI-027
- Generic Name
- OSI-027
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H22N6O3
- CAS Number
- 936890-98-1
- Unique Ingredient Identifier
- 25MKH1SZ0M
- Background
OSI-027 has been used in trials studying the treatment of Any Solid Tumor or Lymphoma.
- Associated Conditions
- -
- Associated Therapies
- -
Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2013-04-15
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 128
- Registration Number
- NCT00698243
- Locations
- 🇺🇸
Karmanos Cancer Institute, Detroit, Michigan, United States
🇧🇪University Hospitals Leuven, Leuven, Belgium
🇬🇧Royal Mardsen Hospital, Sutton, Surrey, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath